SlideShare a Scribd company logo
© 2014 Denver Public Health 
Mapping the Colorado Immunization Information System in 
the Denver Area 
Lauren Elizabeth Snyder, MPH Denver Public Health Applied Public Health Fellowship Program 
Sept. 25, 2014 
GeCo in the Rockies
© 2014 Denver Public Health 
•Key terms 
•Why CIIS? 
•Applications 
•The challenges 
–Rates and deciding on a denominator 
•Next steps 
Agenda
© 2014 Denver Public Health 
Key terms 
•Immunization Information Systems 
•Vaccine Schedule 
•Healthy People 2020 
•Antigen 
•Incidence
© 2014 Denver Public Health 
Why CIIS? 
CIIS Mapping 
Spatial Visualization 
Informatics 
Public Health
© 2014 Denver Public Health 
Source: http://www.vaccines.gov/basics/protection/ 
Public Health
© 2014 Denver Public Health 
Source: http://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html 
Informatics
© 2014 Denver Public Health 
Spatial Visualization
© 2014 Denver Public Health 
Estimated Vaccination Coverage,*† with Individual Vaccines and Selected Vaccination Series Among Children Aged 19-35 Months§ by State -- National Immunization Survey, United States, 2013 
Antigen 
3+DTaP¶ 
4+DTaP** 
3+Polio†† 
1+MMR §§ 
3+Hib¶¶ 
Hib- PS*** 
Hib- FS††† 
3+HepB§§§ 
HepB Birth dose¶¶¶ 
1+Var** ** 
3+PCV† ††† 
4+PCV§ §§§ 
1+HepA¶¶¶¶ 
2+HepA***** 
Rotavirus††††† 
4:3:1§§§ §§ 
4:3:1:3 ¶¶¶¶¶ 
US National 
94.1±0.9 
83.1±1.3 
92.7±1.0 
91.9±0.9 
92.8±0.9 
93.7±0.9 
82.0±1.3 
90.8±1.0 
74.2±1.4 
91.2±0.9 
92.4±1.0 
82.0±1.3 
83.1±1.2 
54.7±1.6 
72.6±1.5 
81.5±1.3 
81.1±1.3 
Colorado 
91.7±4.5 
81.2±6.0 
90.3±4.7 
86.0±5.5 
90.1±4.8 
90.8±4.8 
82.8±5.8 
84.1±5.6 
60.2±7.3 
84.8±5.6 
91.0±4.6 
84.0±5.6 
73.2±6.6 
47.6±7.4 
73.8±6.6 
79.7±6.1 
78.9±6.2 
Antigen 
4:3:1:3- PS****** 
4:3:1:4- FS†††††† 
4:3:1:3:3 §§§§§§ 
4:3:1:3:3-PS¶¶¶¶¶¶ 
4:3:1:4:3- FS******* 
4:3:1:3:3:1†††††† † 
4:3:1:0:3:1§§§§§§§ 
4:3:1:3:3:1- PS¶¶¶¶¶¶¶ 
4:3:1:4:3:1- FS******* * 
4:3:1:3:3:1:4††††††† † 
4:3:1:0:3:1:4§§§§§§§ § 
4:3:1:3:3:1:4- PS¶¶¶¶¶¶¶ ¶ 
4:3:1:4:3:1:4- FS******* ** 
US National 
81.2±1.3 
77.1±1.4 
78.7±1.3 
78.8±1.3 
75.0±1.4 
77.7±1.4 
77.9±1.4 
77.7±1.4 
74.0±1.4 
72.6±1.5 
72.7±1.5 
72.7±1.5 
70.4±1.5 
Colorado 
78.9±6.2 
77.4±6.3 
73.4±6.7 
73.4±6.7 
72.2±6.7 
72.1±6.8 
72.9±6.7 
72.1±6.8 
71.0±6.8 
70.3±6.9 
70.3±6.9 
70.3±6.9 
69.2±6.9 
*Highlighted indicates below national average; red font indicates below healthy people 2020 target
© 2014 Denver Public Health 
Estimated Vaccination Coverage,*† with Individual Vaccines and Selected Vaccination Series Among Children Aged 19-35 Months§ by State -- National Immunization Survey, United States, 2013 
Antigen 
3+DTaP¶ 
4+DTaP** 
3+Polio†† 
1+MMR §§ 
3+Hib¶¶ 
Hib- PS*** 
Hib- FS††† 
3+HepB§§§ 
HepB Birth dose¶¶¶ 
1+Var** ** 
3+PCV† ††† 
4+PCV§ §§§ 
1+HepA¶¶¶¶ 
2+HepA***** 
Rotavirus††††† 
4:3:1§§§ §§ 
4:3:1:3 ¶¶¶¶¶ 
US National 
94.1±0.9 
83.1±1.3 
92.7±1.0 
91.9±0.9 
92.8±0.9 
93.7±0.9 
82.0±1.3 
90.8±1.0 
74.2±1.4 
91.2±0.9 
92.4±1.0 
82.0±1.3 
83.1±1.2 
54.7±1.6 
72.6±1.5 
81.5±1.3 
81.1±1.3 
Colorado 
91.7±4.5 
81.2±6.0 
90.3±4.7 
86.0±5.5 
90.1±4.8 
90.8±4.8 
82.8±5.8 
84.1±5.6 
60.2±7.3 
84.8±5.6 
91.0±4.6 
84.0±5.6 
73.2±6.6 
47.6±7.4 
73.8±6.6 
79.7±6.1 
78.9±6.2 
Antigen 
4:3:1:3- PS****** 
4:3:1:4- FS†††††† 
4:3:1:3:3 §§§§§§ 
4:3:1:3:3-PS¶¶¶¶¶¶ 
4:3:1:4:3- FS******* 
4:3:1:3:3:1†††††† † 
4:3:1:0:3:1§§§§§§§ 
4:3:1:3:3:1- PS¶¶¶¶¶¶¶ 
4:3:1:4:3:1- FS******* * 
4:3:1:3:3:1:4††††††† † 
4:3:1:0:3:1:4§§§§§§§ § 
4:3:1:3:3:1:4- PS¶¶¶¶¶¶¶ ¶ 
4:3:1:4:3:1:4- FS******* ** 
US National 
81.2±1.3 
77.1±1.4 
78.7±1.3 
78.8±1.3 
75.0±1.4 
77.7±1.4 
77.9±1.4 
77.7±1.4 
74.0±1.4 
72.6±1.5 
72.7±1.5 
72.7±1.5 
70.4±1.5 
Colorado 
78.9±6.2 
77.4±6.3 
73.4±6.7 
73.4±6.7 
72.2±6.7 
72.1±6.8 
72.9±6.7 
72.1±6.8 
71.0±6.8 
70.3±6.9 
70.3±6.9 
70.3±6.9 
69.2±6.9 
*Highlighted indicates below national average; red font indicates below healthy people 2020 target 
Take away message is that CO is behind national immunization levels for young children and not currently on track to meet the healthy people 2020 target
© 2014 Denver Public Health 
Background 
Colorado Immunization Information System: 
•Statewide, confidential, computerized 
•Maintains records for children & adults 
•Financial incentive (through Meaningful Use), but not required to report to CIIS 
•Patients and providers can opt out 
•As of May 2014, CIIS held approximately 45.3 million immunization services for 4.2 million individuals.
© 2014 Denver Public Health 
Applications 
•Overall vs. antigen specific penetration 
•Up to date/ not up to date 
•Incidence 
•Protecting confidentiality 
Confirmed Pertussis Cases, 0-18 years, Denver County, 2012
© 2014 Denver Public Health 
Rates 
•Important and difficult 
–Number affected, infected, immune 
–Choosing a denominator is tricky 
•In and out movement of people 
•Young and old age groups especially of interest 
•Differing data sources locate people differently
© 2014 Denver Public Health 
•Federally administered 
•Collected every ten years 
•Attempts to sample everyone 
2010 Census 
•Small sample collected every year, 5 yr average 
•5 year age groupings 
•Not recommended for population estimates 
American Community Survey 5 year estimate 
•Associated cost, new data pulls each year and age groups, concern for public health 
•Less institutional knowledge about methodology 
Commercial 2013 estimate 
•New data source 
•Issues with patient and provider opt out, data cleanliness 
CIIS counts 
Deciding on a Denominator 
Trust 
Timeliness/growth
© 2014 Denver Public Health 
Differences with Denominators
© 2014 Denver Public Health 
Suggestions/Recommendations 
•Know your data, know your audience 
•Make logic clear on maps 
•Series of maps can be helpful to end users 
•Generally, ACS is not recommended for population estimates
© 2014 Denver Public Health 
Next steps 
•Spatial analysis: 
–Immunization status and disease incidence correlation, other factors and models 
•Ordinary Least Squares and Moran’s I 
–Mapping in a business intelligence context 
–Regional mapping 
–Bivariate mapping
© 2014 Denver Public Health 
Acknowledgements: (DPH Team) 
Arthur Davidson, MD, MSPH Dean McEwen, MBA Moises Maravi, MSc 
Judy Shlay, MD, MSPH Christie Mettenbrink, MSPH Theresa Mickiewicz, MSPH Kaylynn Aiona, MPH Kelly Gerard, MS Lourdes Yun, MD, MSPH Kathryn DeYoung, MS 
This study/report was supported in part by an appointment to the Applied Public Health Informatics Fellowship Program administered by CSTE and funded by the Centers for Disease Control and Prevention (CDC) Cooperative Agreement 3U38HM000414-04W1.
© 2014 Denver Public Health 
Questions? 
Lauren.snyder@dhha.org 
303.602.3680

More Related Content

Mapping the Colorado Immunization Information System in the Denver Area

  • 1. © 2014 Denver Public Health Mapping the Colorado Immunization Information System in the Denver Area Lauren Elizabeth Snyder, MPH Denver Public Health Applied Public Health Fellowship Program Sept. 25, 2014 GeCo in the Rockies
  • 2. © 2014 Denver Public Health •Key terms •Why CIIS? •Applications •The challenges –Rates and deciding on a denominator •Next steps Agenda
  • 3. © 2014 Denver Public Health Key terms •Immunization Information Systems •Vaccine Schedule •Healthy People 2020 •Antigen •Incidence
  • 4. © 2014 Denver Public Health Why CIIS? CIIS Mapping Spatial Visualization Informatics Public Health
  • 5. © 2014 Denver Public Health Source: http://www.vaccines.gov/basics/protection/ Public Health
  • 6. © 2014 Denver Public Health Source: http://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html Informatics
  • 7. © 2014 Denver Public Health Spatial Visualization
  • 8. © 2014 Denver Public Health Estimated Vaccination Coverage,*† with Individual Vaccines and Selected Vaccination Series Among Children Aged 19-35 Months§ by State -- National Immunization Survey, United States, 2013 Antigen 3+DTaP¶ 4+DTaP** 3+Polio†† 1+MMR §§ 3+Hib¶¶ Hib- PS*** Hib- FS††† 3+HepB§§§ HepB Birth dose¶¶¶ 1+Var** ** 3+PCV† ††† 4+PCV§ §§§ 1+HepA¶¶¶¶ 2+HepA***** Rotavirus††††† 4:3:1§§§ §§ 4:3:1:3 ¶¶¶¶¶ US National 94.1±0.9 83.1±1.3 92.7±1.0 91.9±0.9 92.8±0.9 93.7±0.9 82.0±1.3 90.8±1.0 74.2±1.4 91.2±0.9 92.4±1.0 82.0±1.3 83.1±1.2 54.7±1.6 72.6±1.5 81.5±1.3 81.1±1.3 Colorado 91.7±4.5 81.2±6.0 90.3±4.7 86.0±5.5 90.1±4.8 90.8±4.8 82.8±5.8 84.1±5.6 60.2±7.3 84.8±5.6 91.0±4.6 84.0±5.6 73.2±6.6 47.6±7.4 73.8±6.6 79.7±6.1 78.9±6.2 Antigen 4:3:1:3- PS****** 4:3:1:4- FS†††††† 4:3:1:3:3 §§§§§§ 4:3:1:3:3-PS¶¶¶¶¶¶ 4:3:1:4:3- FS******* 4:3:1:3:3:1†††††† † 4:3:1:0:3:1§§§§§§§ 4:3:1:3:3:1- PS¶¶¶¶¶¶¶ 4:3:1:4:3:1- FS******* * 4:3:1:3:3:1:4††††††† † 4:3:1:0:3:1:4§§§§§§§ § 4:3:1:3:3:1:4- PS¶¶¶¶¶¶¶ ¶ 4:3:1:4:3:1:4- FS******* ** US National 81.2±1.3 77.1±1.4 78.7±1.3 78.8±1.3 75.0±1.4 77.7±1.4 77.9±1.4 77.7±1.4 74.0±1.4 72.6±1.5 72.7±1.5 72.7±1.5 70.4±1.5 Colorado 78.9±6.2 77.4±6.3 73.4±6.7 73.4±6.7 72.2±6.7 72.1±6.8 72.9±6.7 72.1±6.8 71.0±6.8 70.3±6.9 70.3±6.9 70.3±6.9 69.2±6.9 *Highlighted indicates below national average; red font indicates below healthy people 2020 target
  • 9. © 2014 Denver Public Health Estimated Vaccination Coverage,*† with Individual Vaccines and Selected Vaccination Series Among Children Aged 19-35 Months§ by State -- National Immunization Survey, United States, 2013 Antigen 3+DTaP¶ 4+DTaP** 3+Polio†† 1+MMR §§ 3+Hib¶¶ Hib- PS*** Hib- FS††† 3+HepB§§§ HepB Birth dose¶¶¶ 1+Var** ** 3+PCV† ††† 4+PCV§ §§§ 1+HepA¶¶¶¶ 2+HepA***** Rotavirus††††† 4:3:1§§§ §§ 4:3:1:3 ¶¶¶¶¶ US National 94.1±0.9 83.1±1.3 92.7±1.0 91.9±0.9 92.8±0.9 93.7±0.9 82.0±1.3 90.8±1.0 74.2±1.4 91.2±0.9 92.4±1.0 82.0±1.3 83.1±1.2 54.7±1.6 72.6±1.5 81.5±1.3 81.1±1.3 Colorado 91.7±4.5 81.2±6.0 90.3±4.7 86.0±5.5 90.1±4.8 90.8±4.8 82.8±5.8 84.1±5.6 60.2±7.3 84.8±5.6 91.0±4.6 84.0±5.6 73.2±6.6 47.6±7.4 73.8±6.6 79.7±6.1 78.9±6.2 Antigen 4:3:1:3- PS****** 4:3:1:4- FS†††††† 4:3:1:3:3 §§§§§§ 4:3:1:3:3-PS¶¶¶¶¶¶ 4:3:1:4:3- FS******* 4:3:1:3:3:1†††††† † 4:3:1:0:3:1§§§§§§§ 4:3:1:3:3:1- PS¶¶¶¶¶¶¶ 4:3:1:4:3:1- FS******* * 4:3:1:3:3:1:4††††††† † 4:3:1:0:3:1:4§§§§§§§ § 4:3:1:3:3:1:4- PS¶¶¶¶¶¶¶ ¶ 4:3:1:4:3:1:4- FS******* ** US National 81.2±1.3 77.1±1.4 78.7±1.3 78.8±1.3 75.0±1.4 77.7±1.4 77.9±1.4 77.7±1.4 74.0±1.4 72.6±1.5 72.7±1.5 72.7±1.5 70.4±1.5 Colorado 78.9±6.2 77.4±6.3 73.4±6.7 73.4±6.7 72.2±6.7 72.1±6.8 72.9±6.7 72.1±6.8 71.0±6.8 70.3±6.9 70.3±6.9 70.3±6.9 69.2±6.9 *Highlighted indicates below national average; red font indicates below healthy people 2020 target Take away message is that CO is behind national immunization levels for young children and not currently on track to meet the healthy people 2020 target
  • 10. © 2014 Denver Public Health Background Colorado Immunization Information System: •Statewide, confidential, computerized •Maintains records for children & adults •Financial incentive (through Meaningful Use), but not required to report to CIIS •Patients and providers can opt out •As of May 2014, CIIS held approximately 45.3 million immunization services for 4.2 million individuals.
  • 11. © 2014 Denver Public Health Applications •Overall vs. antigen specific penetration •Up to date/ not up to date •Incidence •Protecting confidentiality Confirmed Pertussis Cases, 0-18 years, Denver County, 2012
  • 12. © 2014 Denver Public Health Rates •Important and difficult –Number affected, infected, immune –Choosing a denominator is tricky •In and out movement of people •Young and old age groups especially of interest •Differing data sources locate people differently
  • 13. © 2014 Denver Public Health •Federally administered •Collected every ten years •Attempts to sample everyone 2010 Census •Small sample collected every year, 5 yr average •5 year age groupings •Not recommended for population estimates American Community Survey 5 year estimate •Associated cost, new data pulls each year and age groups, concern for public health •Less institutional knowledge about methodology Commercial 2013 estimate •New data source •Issues with patient and provider opt out, data cleanliness CIIS counts Deciding on a Denominator Trust Timeliness/growth
  • 14. © 2014 Denver Public Health Differences with Denominators
  • 15. © 2014 Denver Public Health Suggestions/Recommendations •Know your data, know your audience •Make logic clear on maps •Series of maps can be helpful to end users •Generally, ACS is not recommended for population estimates
  • 16. © 2014 Denver Public Health Next steps •Spatial analysis: –Immunization status and disease incidence correlation, other factors and models •Ordinary Least Squares and Moran’s I –Mapping in a business intelligence context –Regional mapping –Bivariate mapping
  • 17. © 2014 Denver Public Health Acknowledgements: (DPH Team) Arthur Davidson, MD, MSPH Dean McEwen, MBA Moises Maravi, MSc Judy Shlay, MD, MSPH Christie Mettenbrink, MSPH Theresa Mickiewicz, MSPH Kaylynn Aiona, MPH Kelly Gerard, MS Lourdes Yun, MD, MSPH Kathryn DeYoung, MS This study/report was supported in part by an appointment to the Applied Public Health Informatics Fellowship Program administered by CSTE and funded by the Centers for Disease Control and Prevention (CDC) Cooperative Agreement 3U38HM000414-04W1.
  • 18. © 2014 Denver Public Health Questions? Lauren.snyder@dhha.org 303.602.3680